How can companies successfully engage with stakeholders to support better access to treatment for patients? In this Pharmaceutical Executive article, Andrew Butcher and Brian Kennedy, Executive Director of Alliance for Patient Access, outline six steps that help maximize the prospects for success in light of the evolving dynamics in stakeholder relationships.
Click here to read the article.
An evidence-based framework to determine funding requirements for NCCPs
The report finds that NCCPs rarely specify the funds that need to be committed or the spending that occurs in practice. When evidence of funding impact is...